Keywords: net, income, leaps, roche, pharma, sales, disappoint
Net income leaps 50% at Roche in 2000, but pharma sales disappoint
Article | 28 February 2001
Roche of Switzerland has posted strong growth for 2000, with salesreaching 27.54 billion Swiss francs ($16.34 billion), up 8%, while operating profit rose 11% to 7.10 ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
